Ven 20 Mar | Sala B
Session 1: A call for action: assessment of non-lipidic high-risk plaques and possible therapeutic options
Moderators: Davide Capodanno (Catania), Michael Papafaklis (Patras - Greece)
12.30 Pathophysiology of ACS: ulcerative and intact fibrous cap thrombosis
Fernando Alfonso (Madrid - Spain)
12.40 Calcium is not all the same
Eloisa Arbustini (Pavia)
12.50 Plaque haemorrhage: diagnosis, prevalence and prognostic impact
Francesco Prati (Rome)
13.00 Breakthrough technology for plaque assessment: photon-counting CT
Filippo Cademartiri (Naples)
13.10 CT-PET strategies for identifying high-risk plaques
Michela Ferrari (Pavia)
13.20 Discussion
Expert Discussants: Paolo Canova (Bergamo), Enrico Cerrato (Rivoli - TO), Arturo Cesaro (Caserta)
Session 2: RATIONALE FOR TRIALS OF PLAQUE PASSIVATION
Moderators: Fernando Alfonso (Madrid - Spain), James Muller (Boston, MA - USA)
13.35 Update on strategy intervention trials on plaque vulnerability
Elvin Kedhi (Montreal - Canada)
13.45 Update on strategy pharmaceutical trials on plaque vulnerability
Lorenz Räber (Bern)
13.55 Rationale for pre-emptive treatment of calcified nodules
Enrico Romagnoli (Rome)
14.05 Anti-inflammatory drugs for preventive plaque ulceration and intact fibrous cap thrombosis
Flavio Giuseppe Biccirè (Rome)
14.15 Discussion
Expert Discussants: Simone Budassi (Rome), Rocco Vergallo (Genoa), Giampiero Vizzari (Messina)
